Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.07
-0.53 (-8.03%)
At close: Mar 24, 2026, 4:00 PM EDT
6.05
-0.02 (-0.30%)
After-hours: Mar 24, 2026, 6:53 PM EDT

Cartesian Therapeutics Revenue

In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%. Cartesian Therapeutics had revenue of $947.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$2.80M
Revenue Growth
-92.81%
P/S Ratio
57.53
Revenue / Employee
$37,293
Employees
75
Market Cap
160.91M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K-7.88M-97.44%
Dec 31, 20168.08M2.07M34.47%
Dec 31, 20156.01M2.97M97.73%
Dec 31, 20143.04M1.56M105.54%
Dec 31, 20131.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics149.50M
Sutro Biopharma105.65M
Protalix BioTherapeutics52.74M
Caribou Biosciences11.16M
Whitehawk Therapeutics7.15M
Cibus3.64M
Molecular Partners AG856.30K
Adagene103.20K
Revenue Rankings

RNAC News

More News